Barclays’s Conformis, Inc. Common Stock CFMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,227
Closed -$179K 5100
2021
Q2
$179K Buy
6,227
+6,163
+9,630% +$146K ﹤0.01% 3605
2021
Q1
$2K Buy
+64
New +$1.73K ﹤0.01% 4576
2020
Q3
Sell
-740
Closed -$15K 5732
2020
Q2
$15K Sell
740
-116
-14% -$2.42K ﹤0.01% 5266
2020
Q1
$14K Sell
856
-1,730
-67% -$42.3K ﹤0.01% 5738
2019
Q4
$97K Buy
2,586
+1,309
+103% +$62.1K ﹤0.01% 5497
2019
Q3
$59K Sell
1,277
-2,002
-61% -$120K ﹤0.01% 5824
2019
Q2
$358K Sell
3,279
-1,193
-27% -$98.3K ﹤0.01% 4620
2019
Q1
$322K Buy
+4,472
New +$128K ﹤0.01% 4472
2018
Q4
Sell
-24
Closed -$1K 7506
2018
Q3
$1K Sell
24
-261
-92% -$7.1K ﹤0.01% 7056
2018
Q2
$9K Sell
285
-176
-38% -$6.08K ﹤0.01% 6585
2018
Q1
$17K Buy
461
+191
+71% +$8.02K ﹤0.01% 6500
2017
Q4
$16K Sell
270
-1,912
-88% -$153K ﹤0.01% 6388
2017
Q3
$192K Buy
2,182
+2,169
+16,685% +$215K ﹤0.01% 4463
2017
Q2
$1K Sell
13
-7
-35% -$841 ﹤0.01% 6558
2017
Q1
$3K Buy
20
+7
+54% +$1.18K ﹤0.01% 6419
2016
Q4
$3K Sell
13
-8
-38% -$1.77K ﹤0.01% 6290
2016
Q3
$5K Sell
21
-175
-89% -$35.2K ﹤0.01% 6035
2016
Q2
$34K Buy
+196
New +$46.1K ﹤0.01% 5040

Other funds holding CFMS

Barclays's CFMS Position: Q3 2021 in Review

Barclays sold out of Conformis, Inc. Common Stock (CFMS) in Q3 2021, closing a stake of 6,227 shares — an estimated $179K sold.

Barclays first reported a position in CFMS in Q2 2016 and held it in 18 quarters. The position peaked at $358K in Q2 2019. 80 funds tracked by Wall St. Rank hold CFMS as of Q3 2021.

  • Barclays reported no remaining Conformis, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Barclays sold 6,227 Conformis, Inc. Common Stock shares in Q3 2021, an estimated $179K.
  • Barclays first reported a position in Conformis, Inc. Common Stock in Q2 2016 and held it in 18 quarters.
  • Barclays's Conformis, Inc. Common Stock position peaked at $358K in Q2 2019.
  • 80 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q3 2021.

Based on Barclays's 13F filing for Q3 2021, filed 9 Nov 2021.